The cost-effectiveness of hiv prevention from a managed care perspective

Journal of Public Health Management and Practice

Volumn 4, Issue 1, 1998, Pages 59-66

  Pinkerton, Steven D ^a   Holtgrave, David R ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cost effectiveness; HIV prevention; Managed care

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PREVENTIVE HEALTH SERVICE; REVIEW; UNITED STATES;

COST-BENEFIT ANALYSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MANAGED CARE PROGRAMS; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 0031610698     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/00124784-199801000-00011     Document Type: Article

References (31)

1. Gordon, R.L., et al. 1996. Prevention and Reforming the U.S. health care system: Changing roles and responsibilities for public health. Annual Review of Public Health 17: 489-509.
2. Centers for Disease Control and Prevention. 1997a.
3. Carpenter C.C.J., et al. 1996. Antiretroviral therapy for HIV infection in 1996. journal of the American Medical Association 276: 146-154.
4. Booth, R.E., and J.K Watters. 1994. How effective are risk-reduction interventions targeting injecting drug users? AIDS 8: 1515-1524.
5. Choi, K.H., and T.J. Coates. 1994. Prevention of HIV Infection. AIDS 8: 1371-1389.
6. Holtgrave, D.R., et al. 1995. An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Reports 110: 134-146.
7. Holtgrave, D.R., et al. 1996. Economic evaluation of HIV prevention programs. Annual Review of Public Health 17: 467-488.
8. Drummond, M.F., et al. 1987. Methods for the economic evaluation of health care programmes. New York: Oxford University Press.
9. Haddix, A.C., et al., eds. 1996. Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press.
10. Gold, M.R., et al., eds. 1996. Cost-effectiveness in health and medicine. New York: Oxford University Press.
11. Fabian, R. 1994. The QALY approach. In: Valuing health for policy: An economic approach, G.L. Tolley, et al., eds. Chicago: University of Chicago Press.
12. Laupacis, A., et al. 1993. Tentative guidelines for using clinical and economic evaluations revisited. Canadian Medical Association Journal 148: 927-929.
13. Holtgrave, D.R., andS.D. Pinkerton. 1997. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of the Acquired Immune Deficiency Syndromes and Human Retrovirology, forthcoming.
14. Russell, L.B. 1993. The role of prevention in health reform. The New England Journal of Medicine 329: 352-354.
15. Holtgrave, D.R., and J.A. Kelly. 1996. Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. American lournai of Public Health 86: 1442-1445.
16. Holtgrave, D.R., and J.A. Kelly. 1997. The Cost-effectiveness of an HIV prevention intervention for gay men. AIDS & Behavior 1:173-180
17. Pinkerton, S.D., et al., 1997. Cost-effectiveness of HIV prevention skills training for men who have sex with men. AIDS 11:347-357.
18. Kelly, J.A., et al. 1992. Community AIDS/HIV risk reduction: The effects of endorsements by popular people in three cities. American Journal of Public Health 82: 1483-1489.
19. Pinkerton, S.D., et al. Cost-effective ness of a community-level HIV risk reduction intervention. American Journal of Public Health, under review.
20. Conner, E.M., et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with Zidovudine treatment. New England Journal of Medicine 331: 1173-1180.
21. Gorsky, R.D., et al. 1996. Preventing perinatal HIV transmission: Costs and effectiveness of a recommended intervention. Public Health Reports 111: 335-341.
22. Lindfors, K.K., and J. Rosenquist. 1995. The cost-effectiveness of mammographic screening strategies. Journal of the American Medical Association 274: 881-884.
23. Anonymous. 1996. New drugs for HIV infection. The Medical Letter on Drugs and Therapeutics 38: 35-38.
24. Deeks, S.G., et al. 1996. HIV-1 protease inhibitors: A review for clinicians. Journal of the American Medical Association 2 77: 145-153.
25. Centers for Disease Control and Prevention. 1995. Prevention and managed care: Opportunities for managed care organization, purchasers of health care, and public health agencies. Morbidity and Mortality Weekly Report 44, no. RR-14: 1-12.
26. U.S. Preventive Services Task Force. 1996. Guide to clinical preventive services (second edition). Baltimore, MD: Williams and Wilkins.
27. Cummings, S.R., et al. 1989. The cost-effectiveness of counseling smokers to quit. Journal of the American Medical Association 261: 75-79.
28. Kamb, M.L., et al. 1996. A multi-center, randomized controlled trial evaluating HIV prevention counseling (Project Respect): preliminary results. Presented at XI International Conference on AIDS (Abstract Th.C.4380), Vancouver, British Columbia, 1996.
29. Kelly, J.A., et al. 1993. Psychological interventions to prevent HIV infection are urgently needed. American Psychologist 48: 1023-1034.
30. Lawrence, D.M. 1995. Welcoming presentation to the Henry J. Kaiser Family Foundation Forum on AIDS and managed care. Journal of the Acquired Immune Deficiency Syndromes and Human Retrovirology 8: S4-S6
31. Vogt, T.M., et al. 1994. Prevention in managed care. Western Journal of Medicine 161: 63-64.